TXNRD1 and cardiac hypertrophy: Cardiac hypertrophy in response to triiodothyronine or isoproterenol treatment was found to upregulate the expression of MsrB1, GPX3, GPx4, and Txnrd1 [112], leading to the speculation that their increased expression may mitigate cardiac damage following induction of hypertrophy.